← Leaderboards
David E. Heppner
University Of Vermont & St Agric College
$852,276
Attributed
$852,276
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $401.2K · FY2016–25$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$852,276 · 2
By mechanism
R35$802,459 · 1
F32$49,817 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Vermont & St Agric College
Same institution · by research overlap
- Vikas Anathy$7,275,162
- Albert Van Der Vliet$14,217,675
- Benedek Erdos$3,144,353
- Thomas Patrick Ahern$1,726,733
- Christopher Michael Dustin$61,664
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationMolecularPhosphotransferasesBreathingInsightEpidermal Growth Factor ReceptorLinkProductionInhibitorExhibitsFutureBiological ModelsKinase InhibitorDrug DevelopmentDecision MakingDrug DiscoveryChemical PropertyAccelerationChemical StructureBindingDesignDrug DesignEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorConsumption
Grant awards (3)
Improving Drug Development Through Studies of Protein Kinase Inhibitors$401,217
R35 · FY2025 · GM · contact PI
Improving Drug Development Through Studies of Protein Kinase Inhibitors$401,242
R35 · FY2024 · GM · contact PI
Investigations of Redox-dependent Processes of the Airway Epithelium$49,817
F32 · FY2016 · HL · contact PI